DBV Technologies' VIASKIN Peanut Patch Shows Significant Benefit for Young Children in Phase 3 VITESSE Trial
Market Chameleon (Wed, 17-Dec 10:29 AM)
DBV Technologies' VIASKIN Peanut Patch Achieves Significant Milestone in Phase 3 Trial for Peanut Allergy
Market Chameleon (Wed, 17-Dec 7:05 AM)
DBV Technologies Updates Shareholders on Voting Rights: Over 200 Million Shares, Transparent Breakdown Revealed
Market Chameleon (Wed, 3-Dec 9:03 AM)
